Medtronic plc (NYSE:MDT)
Market Cap | 107.26B |
---|---|
Revenue | 30.77B |
Gross Profit | 20.44B |
Shares Out | 1.33B |
EPS (ttm) | 3.04 |
PE Ratio | 25.9146 |
Forward PE | 15.0074 |
Dividend Rate (ttm) | 2.6855 |
Dividend Yield | 0.0339 |
Trading Day | Mar 31 |
---|---|
Last Price | $80.62 |
Previous Close | $79.18 |
Change ($) | 1.44 |
Change (%) | 1.82% |
Day's Open | 79.65 |
Day's Range | 79.24 - 80.63 |
Day's Volume | 5.56M |
52 Week Range | 74.46 - 110.6 |
About Medtronic plc
Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries.
The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
News
Quick info
Hatch Street Lower
Dublin
DUBLIN
Medtronic plc income statements (2022) (USD)
June 2022 | June 2022 | March 2022 | |
---|---|---|---|
Total Revenue | 8.09B | 8.09B | 7.76B |
Cost of Revenue | 2.59B | 2.59B | 2.46B |
Gross Profit | 5.50B | 5.50B | 5.30B |
Research & Development | 652M | 652M | 668M |
Selling General & Admin | 2.57B | 2.57B | 2.56B |
Operating Expense | 6.33B | 6.33B | 6.12B |
Operating Income | 1.76B | 1.76B | 1.64B |
Other Income Expense Net | -63M | -63M | 63M |
EBIT | 1.70B | 1.70B | 1.71B |
Interest Income | 143M | 143M | 137M |
Pretax Income | 1.60B | 1.60B | 1.59B |
Income Tax | 109M | 109M | 106M |
Minority Interest | 6M | 6M | 4M |
Net Income | 1.49B | 1.49B | 1.48B |
Net Income Basic | 1.49B | 1.49B | 1.48B |
Medtronic plc income statements (2021) (USD)
December 2021 | September 2021 | June 2021 | March 2021 | |
---|---|---|---|---|
Total Revenue | 7.85B | 7.99B | 8.19B | 7.78B |
Cost of Revenue | 2.50B | 2.60B | 2.65B | 2.62B |
Gross Profit | 5.35B | 5.39B | 5.54B | 5.15B |
Research & Development | 676M | 750M | 632M | 601M |
Selling General & Admin | 2.62B | 2.55B | 2.59B | 2.54B |
Operating Expense | 6.24B | 7.09B | 6.52B | 6.29B |
Operating Income | 1.61B | 896M | 1.67B | 1.48B |
Other Income Expense Net | 0 | 0 | 0 | 0 |
EBIT | 1.61B | 896M | 1.67B | 1.48B |
Interest Income | 136M | 137M | 141M | 143M |
Pretax Income | 1.49B | 833M | 1.57B | 1.22B |
Income Tax | 176M | 64M | 201M | -59M |
Minority Interest | 6M | 6M | 6M | 9M |
Net Income | 1.31B | 763M | 1.36B | 1.27B |
Net Income Basic | 1.31B | 763M | 1.36B | 1.27B |
Medtronic plc income statements (2020) (USD)
September 2020 | July 2020 | April 2020 | January 2020 | |
---|---|---|---|---|
Total Revenue | 6.51B | 6.51B | 6B | 7.72B |
Cost of Revenue | 2.51B | 2.95B | 2.67B | 2.79B |
Gross Profit | 4B | 3.56B | 3.33B | 4.93B |
Research & Development | 621M | 621M | 567M | 573M |
Selling General & Admin | 2.42B | 2.42B | 2.30B | 2.55B |
Operating Expense | 5.87B | 5.98B | 5.54B | 5.91B |
Operating Income | 638M | 524M | 463M | 1.81B |
Other Income Expense Net | 0 | 60M | -257M | -226M |
EBIT | 638M | 524M | 463M | 1.81B |
Interest Income | 171M | 171M | 162M | 156M |
Pretax Income | 584M | 584M | 206M | 1.58B |
Income Tax | 93M | 93M | -434M | -340M |
Minority Interest | 4M | 4M | -6M | 4M |
Net Income | 487M | 487M | 646M | 1.92B |
Net Income Basic | 487M | 487M | 646M | 1.92B |
Medtronic plc income statements (2019) (USD)
October 2019 | July 2019 | April 2019 | January 2019 | |
---|---|---|---|---|
Total Revenue | 7.71B | 7.49B | 8.15B | 7.55B |
Cost of Revenue | 2.80B | 2.78B | 2.89B | 2.68B |
Gross Profit | 4.90B | 4.72B | 5.26B | 4.87B |
Research & Development | 603M | 587M | 594M | 561M |
Selling General & Admin | 2.59B | 2.50B | 2.58B | 2.58B |
Operating Expense | 5.99B | 5.87B | 6.06B | 5.82B |
Operating Income | 1.72B | 1.63B | 2.09B | 1.73B |
Other Income Expense Net | -421M | -651M | -798M | -358M |
EBIT | 1.72B | 1.63B | 2.09B | 1.73B |
Interest Income | 165M | 609M | 718M | 243M |
Pretax Income | 1.29B | 0.98B | 1.29B | 1.37B |
Income Tax | -77M | 100M | 110M | 99M |
Minority Interest | 7M | 13M | 10M | 2M |
Net Income | 1.36B | 864M | 1.17B | 1.27B |
Net Income Basic | 1.36B | 864M | 1.17B | 1.27B |
Medtronic plc income statements (2018) (USD)
October 2018 | July 2018 | April 2018 | January 2018 | |
---|---|---|---|---|
Total Revenue | 7.48B | 7.38B | 8.14B | 7.37B |
Cost of Revenue | 2.63B | 2.64B | 2.82B | 2.64B |
Gross Profit | 4.86B | 4.75B | 5.32B | 4.73B |
Research & Development | 590M | 585M | 592M | 558M |
Selling General & Admin | 2.57B | 2.54B | 2.53B | 2.49B |
Operating Expense | 5.79B | 5.76B | 5.95B | 5.68B |
Operating Income | 1.69B | 1.63B | 2.20B | 1.69B |
Other Income Expense Net | -336M | -446M | -474M | -660M |
EBIT | 1.69B | 1.63B | 2.20B | 1.69B |
Interest Income | 241M | 242M | 317M | 270M |
Pretax Income | 1.36B | 1.18B | 1.73B | 1.03B |
Income Tax | 235M | 103M | 260M | 2.42B |
Minority Interest | 5M | 2M | 5M | -3M |
Net Income | 1.12B | 1.08B | 1.46B | -1.39B |
Net Income Basic | 1.12B | 1.08B | 1.46B | -1.39B |
Medtronic plc income statements (2017) (USD)
October 2017 | July 2017 | April 2017 | |
---|---|---|---|
Total Revenue | 7.05B | 7.39B | 7.92B |
Cost of Revenue | 2.56B | 2.79B | 2.93B |
Gross Profit | 4.49B | 4.60B | 4.98B |
Research & Development | 555M | 548M | 553M |
Selling General & Admin | 2.44B | 2.48B | 2.48B |
Operating Expense | 5.55B | 5.82B | 5.96B |
Operating Income | 1.50B | 1.57B | 1.90B |
Other Income Expense Net | 230M | -374M | -469M |
EBIT | 1.50B | 1.57B | 1.90B |
Interest Income | 273M | 286M | 290M |
Pretax Income | 1.73B | 1.20B | 1.44B |
Income Tax | -285M | 186M | 271M |
Minority Interest | -4M | -7M | 1M |
Net Income | 2.02B | 1.02B | 1.16B |
Net Income Basic | 2.02B | 1.02B | 1.16B |
Medtronic plc balance sheet (2022) (USD)
June 2022 | June 2022 | March 2022 | |
---|---|---|---|
Current Cash | 10.57B | 10.57B | 11.22B |
Receivables | 5.55B | 5.55B | 5.45B |
Inventory | 4.62B | 4.62B | 4.51B |
Current Assets | 23.06B | 23.06B | 23.30B |
Other Current Assets | 2.32B | 2.32B | 2.12B |
Short Term Investments | 2.32B | 2.32B | 2.12B |
Long Term Investments | 67.92B | 67.92B | 68.50B |
Property/Plant Equipment | 5.41B | 5.41B | 5.25B |
Good Will | N.A | N.A | N.A |
Intangible Assets | 15.60B | 15.60B | 16.08B |
Tangible Assets (Net) | -3.55B | -3.55B | -4.88B |
Other Assets | 2.13B | 2.13B | 2.52B |
Total Assets | 90.98B | 90.98B | 91.80B |
Accounts Payable | 2.28B | 2.28B | 1.99B |
Other Current Liabilities | 6.38B | 6.38B | 6.08B |
Total Current Liabilities | 12.39B | 12.39B | 8.93B |
Total Liabilities | 38.43B | 38.43B | 39.26B |
Long Term Debt | 20.37B | 20.37B | 24.29B |
Current Long Term Debt | 3.74B | 3.74B | 865M |
Minority Interest | 171M | 171M | 171M |
Common Stock | 1.34B | 1.34B | 1.34B |
Treasury Stock | 0 | 0 | 0 |
Retained Earnings | 30.25B | 30.25B | 29.61B |
Capital Surplus | N.A | N.A | N.A |
Shareholder Equity | 52.55B | 52.55B | 52.54B |
Other Liabilities | N.A | N.A | N.A |
Medtronic plc balance sheet (2021) (USD)
December 2021 | September 2021 | March 2021 | |
---|---|---|---|
Current Cash | 10.67B | 10.60B | 14.64B |
Receivables | 5.49B | 5.43B | 5.22B |
Inventory | 4.35B | 4.29B | 4.51B |
Current Assets | 22.73B | 22.43B | 26.35B |
Other Current Assets | 2.22B | 2.12B | 1.99B |
Short Term Investments | 2.22B | 2.12B | 1.99B |
Long Term Investments | 69.03B | 69.37B | 70.92B |
Property/Plant Equipment | 5.19B | 5.16B | 5.02B |
Good Will | N.A | N.A | N.A |
Intangible Assets | 16.52B | 16.89B | 18.24B |
Tangible Assets (Net) | -6.14B | -7.12B | -9.62B |
Other Assets | 2.50B | 2.41B | 2.21B |
Total Assets | 91.76B | 91.80B | 97.27B |
Accounts Payable | 1.92B | 1.86B | 1.82B |
Other Current Liabilities | 5.87B | 5.89B | 6.90B |
Total Current Liabilities | 7.80B | 7.76B | 12.53B |
Total Liabilities | 39.76B | 40.32B | 46.51B |
Long Term Debt | 25.61B | 25.96B | 26.50B |
Current Long Term Debt | 16M | 6M | 3.82B |
Minority Interest | 168M | 178M | 170M |
Common Stock | 1.35B | 1.34B | 1.35B |
Treasury Stock | 0 | 0 | 0 |
Retained Earnings | 28.97B | 28.51B | 28.02B |
Capital Surplus | N.A | N.A | N.A |
Shareholder Equity | 51.99B | 51.49B | 50.76B |
Other Liabilities | N.A | N.A | N.A |
Medtronic plc balance sheet (2020) (USD)
September 2020 | July 2020 | April 2020 | January 2020 | |
---|---|---|---|---|
Current Cash | 13.01B | 6.50B | 4.14B | 3.71B |
Receivables | 4.88B | 4.88B | 4.65B | 6.25B |
Inventory | 4.55B | 4.55B | 4.23B | 4.12B |
Current Assets | 24.51B | 24.51B | 22.03B | 24.04B |
Other Current Assets | 2.07B | 2.07B | 2.21B | 2.05B |
Short Term Investments | 2.07B | 6.51B | 6.81B | 7.92B |
Long Term Investments | 69.40B | N.A | 480M | 33M |
Property/Plant Equipment | 4.88B | 4.88B | 5.76B | 5.76B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 18.67B | 18.67B | 19.06B | 19.46B |
Tangible Assets (Net) | -9.09B | 9.58B | -57.71B | -57.11B |
Other Assets | 2.14B | 2.14B | 687M | 1.17B |
Total Assets | 93.91B | 93.91B | 90.69B | 92.82B |
Accounts Payable | 1.72B | 1.72B | 2B | 1.95B |
Other Current Liabilities | 5.54B | 5.15B | 4.92B | 5.32B |
Total Current Liabilities | 13.09B | 13.09B | 10.37B | 8.74B |
Total Liabilities | 43.61B | 43.46B | 39.82B | 40.87B |
Long Term Debt | 22.87B | 22.87B | 22.80B | 25.58B |
Current Long Term Debt | 5.82B | 5.82B | 2.78B | 844M |
Minority Interest | 147M | 4M | -6M | 4M |
Common Stock | 26.26B | 1.34B | 1.34B | 1.34B |
Treasury Stock | 0 | N.A | N.A | N.A |
Retained Earnings | 27.82B | 27.82B | 28.13B | 28.21B |
Capital Surplus | N.A | 26.26B | 26.17B | 26.14B |
Shareholder Equity | 50.30B | 50.30B | 50.74B | 51.81B |
Other Liabilities | N.A | N.A | N.A | N.A |
Medtronic plc balance sheet (2019) (USD)
October 2019 | July 2019 | April 2019 | January 2019 | |
---|---|---|---|---|
Current Cash | 3.96B | 5.08B | 4.39B | 3.70B |
Receivables | 6.12B | 5.89B | 6.22B | 5.85B |
Inventory | 4.04B | 3.93B | 3.75B | 3.87B |
Current Assets | 22.65B | 22.71B | 21.97B | 20.88B |
Other Current Assets | 2.10B | 2.20B | 2.14B | 2.02B |
Short Term Investments | 6.44B | 5.60B | 5.46B | 5.44B |
Long Term Investments | 44M | 44M | 44M | 44M |
Property/Plant Equipment | 5.75B | 5.66B | 4.68B | 4.59B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 19.78B | 20.23B | 20.56B | 20.84B |
Tangible Assets (Net) | -57.95B | -58.7B | -59.44B | -59.71B |
Other Assets | 1.08B | 1B | 0.97B | 882M |
Total Assets | 91.05B | 91.27B | 89.69B | 88.73B |
Accounts Payable | 1.97B | 1.91B | 1.95B | 1.71B |
Other Current Liabilities | 4.71B | 4.47B | 5.11B | 5.14B |
Total Current Liabilities | 8.17B | 8.52B | 8.47B | 8.85B |
Total Liabilities | 40.33B | 40.77B | 39.48B | 38.79B |
Long Term Debt | 25.59B | 25.60B | 24.49B | 23.67B |
Current Long Term Debt | 875M | 1.46B | 838M | 1.36B |
Minority Interest | 7M | 13M | 10M | 2M |
Common Stock | 1.34B | 1.34B | 1.34B | 1.34B |
Treasury Stock | N.A | N.A | N.A | N.A |
Retained Earnings | 27.02B | 26.38B | 26.27B | 25.77B |
Capital Surplus | 26.17B | 26.47B | 26.53B | 26.52B |
Shareholder Equity | 50.58B | 50.36B | 50.09B | 49.83B |
Other Liabilities | N.A | N.A | N.A | N.A |
Medtronic plc balance sheet (2018) (USD)
October 2018 | July 2018 | April 2018 | January 2018 | |
---|---|---|---|---|
Current Cash | 3.91B | 4.38B | 3.67B | 6.36B |
Receivables | 5.74B | 5.67B | 5.99B | 5.78B |
Inventory | 3.76B | 3.68B | 3.58B | 3.75B |
Current Assets | 21.65B | 22.46B | 22.98B | 26.61B |
Other Current Assets | 2.01B | 2.10B | 2.19B | 2.65B |
Short Term Investments | 6.22B | 6.62B | 7.56B | 8.08B |
Long Term Investments | 44M | 44M | 559M | 645M |
Property/Plant Equipment | 4.54B | 4.52B | 4.60B | 4.52B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 20.82B | 21.27B | 21.72B | 22.18B |
Tangible Assets (Net) | -57.45B | -57.56B | -58.29B | -59.29B |
Other Assets | 1.08B | 1.06B | 519M | 521M |
Total Assets | 88.15B | 89.72B | 91.39B | 95.80B |
Accounts Payable | 1.74B | 1.79B | 1.63B | 1.81B |
Other Current Liabilities | 4.84B | 4.99B | 5.42B | 5.30B |
Total Current Liabilities | 8.46B | 9.11B | 10.08B | 10.93B |
Total Liabilities | 38.44B | 39.39B | 40.57B | 45.46B |
Long Term Debt | 23.67B | 23.68B | 23.70B | 25.92B |
Current Long Term Debt | 1.34B | 1.55B | 2.06B | 2.90B |
Minority Interest | 5M | 2M | 5M | -3M |
Common Stock | 1.35B | 1.35B | 1.35B | 1.36B |
Treasury Stock | N.A | N.A | N.A | N.A |
Retained Earnings | 25.17B | 24.73B | 24.38B | 23.43B |
Capital Surplus | 27.05B | 27.82B | 28.13B | 28.19B |
Shareholder Equity | 49.61B | 50.22B | 50.72B | 50.23B |
Other Liabilities | N.A | N.A | N.A | N.A |
Medtronic plc balance sheet (2017) (USD)
October 2017 | July 2017 | April 2017 | |
---|---|---|---|
Current Cash | 5.53B | 4.69B | 4.97B |
Receivables | 5.75B | 5.78B | 5.59B |
Inventory | 3.64B | 3.54B | 3.34B |
Current Assets | 25.16B | 24.78B | 24.87B |
Other Current Assets | 2.25B | 2.37B | 2.24B |
Short Term Investments | 8B | 8.40B | 8.74B |
Long Term Investments | 869M | 773M | 737M |
Property/Plant Equipment | 4.44B | 4.39B | 4.36B |
Good Will | N.A | N.A | N.A |
Intangible Assets | 22.63B | 23.01B | 23.41B |
Tangible Assets (Net) | -56.59B | -57.54B | -56.5B |
Other Assets | 535M | 6.51B | 6.41B |
Total Assets | 94.46B | 100.25B | 99.82B |
Accounts Payable | 1.72B | 1.76B | 1.73B |
Other Current Liabilities | 4.78B | 4.61B | 4.34B |
Total Current Liabilities | 10.50B | 15.15B | 14.22B |
Total Liabilities | 42.88B | 49.46B | 49.40B |
Long Term Debt | 25.94B | 25.95B | 25.92B |
Current Long Term Debt | 3.13B | 8.06B | 7.52B |
Minority Interest | -4M | -7M | 1M |
Common Stock | 1.35B | 1.35B | 1.37B |
Treasury Stock | N.A | N.A | N.A |
Retained Earnings | 25.44B | 24.04B | 23.36B |
Capital Surplus | 28.09B | 28.55B | 29.55B |
Shareholder Equity | 51.47B | 50.67B | 50.29B |
Other Liabilities | N.A | N.A | N.A |
Medtronic plc cash flow (2022) (USD)
December 2022 | September 2022 | June 2022 | June 2022 | |
---|---|---|---|---|
Net Income | 427M | 0.93B | 1.49B | 1.49B |
Depreciation | 671M | 668M | 688M | 688M |
Changes in Receivables | 5.63B | 5.31B | 5.55B | 5.55B |
Changes in Inventories | 5.06B | 4.81B | 4.62B | 4.62B |
Cash Change | 11.43B | 8.87B | 10.57B | 10.57B |
Cash Flow | 0.92B | 1.08B | 2.06B | 2.06B |
Capital Expenditures | -323M | -426M | -389M | -389M |
Investments | N.A | N.A | N.A | N.A |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | -1.15B | -1.59B | 271M | 271M |
Dividends Paid | N.A | N.A | N.A | N.A |
Net Borrowings | 11.90B | 11.19B | 11.22B | 11.22B |
Other Financing Cash Flows | N.A | N.A | N.A | N.A |
Cash Flow Financing | 3.01B | -0.95B | -1.95B | -1.95B |
Exchange Rate Effect | N.A | N.A | N.A | N.A |
Medtronic plc cash flow (2021) (USD)
March 2021 | |
---|---|
Net Income | 1.27B |
Depreciation | 678M |
Changes in Receivables | 5.22B |
Changes in Inventories | 4.51B |
Cash Change | 14.64B |
Cash Flow | 2.36B |
Capital Expenditures | -363M |
Investments | N.A |
Investing Activity (other) | N.A |
Total Investing Cash Flows | -2.77B |
Dividends Paid | N.A |
Net Borrowings | 13.70B |
Other Financing Cash Flows | N.A |
Cash Flow Financing | -1B |
Exchange Rate Effect | N.A |
Medtronic plc cash flow (2020) (USD)
September 2020 | July 2020 | April 2020 | January 2020 | |
---|---|---|---|---|
Net Income | 487M | 487M | 646M | 1.92B |
Depreciation | 669M | 669M | 672M | 663M |
Changes in Receivables | 231M | -231M | 1.60B | -130M |
Changes in Inventories | 322M | -235M | -231M | -79M |
Cash Change | 2.06B | 2.36B | 431M | -253M |
Cash Flow | 278M | 278M | 1.45B | 2.41B |
Capital Expenditures | -334M | -334M | -336M | -293M |
Investments | N.A | 358M | 0.99B | -1.49B |
Investing Activity (other) | N.A | -16M | -3M | -18M |
Total Investing Cash Flows | 8M | 8M | 365M | -1.8B |
Dividends Paid | N.A | -778M | -724M | -723M |
Net Borrowings | 13.61B | 2.76B | -538M | -37M |
Other Financing Cash Flows | N.A | -51M | -7M | -20M |
Cash Flow Financing | 1.96B | 1.96B | -1.31B | -873M |
Exchange Rate Effect | N.A | 114M | -74M | 14M |
Medtronic plc cash flow (2019) (USD)
October 2019 | July 2019 | April 2019 | January 2019 | |
---|---|---|---|---|
Net Income | 1.36B | 864M | 1.17B | 1.27B |
Depreciation | 671M | 657M | 667M | 675M |
Changes in Receivables | -224M | 328M | -368M | -111M |
Changes in Inventories | -145M | -122M | 93M | -55M |
Cash Change | -1.12B | 687M | 690M | -208M |
Cash Flow | 1.87B | 1.51B | 2.09B | 2.06B |
Capital Expenditures | -283M | -301M | -335M | -302M |
Investments | -866M | -100M | -21M | 792M |
Investing Activity (other) | -11M | -5M | 3M | -3M |
Total Investing Cash Flows | -1.22B | -551M | -529M | -1.01B |
Dividends Paid | -723M | -724M | -671M | -671M |
Net Borrowings | -604M | 620M | -145M | -6M |
Other Financing Cash Flows | -7M | -47M | 4M | -1M |
Cash Flow Financing | -1.74B | -274M | -860M | -1.27B |
Exchange Rate Effect | -28M | 2M | -8M | 14M |
Medtronic plc cash flow (2018) (USD)
October 2018 | July 2018 | April 2018 | January 2018 | |
---|---|---|---|---|
Net Income | 1.12B | 1.08B | 1.46B | -1.39B |
Depreciation | 651M | 666M | 664M | 666M |
Changes in Receivables | -69M | 313M | -212M | -23M |
Changes in Inventories | -132M | -180M | 126M | -45M |
Cash Change | -469M | 711M | -2.69B | 829M |
Cash Flow | 1.16B | 1.70B | 1.04B | 2B |
Capital Expenditures | -206M | -291M | -292M | -252M |
Investments | 342M | 1.04B | 446M | -88M |
Investing Activity (other) | N.A | N.A | -17M | -3M |
Total Investing Cash Flows | 121M | 643M | 111M | -378M |
Dividends Paid | -674M | -677M | -624M | -623M |
Net Borrowings | -199M | -517M | -3.06B | -249M |
Other Financing Cash Flows | 16M | -5M | -5M | -4M |
Cash Flow Financing | -1.73B | -1.57B | -3.83B | -849M |
Exchange Rate Effect | -23M | -61M | -10M | 54M |
Medtronic plc cash flow (2017) (USD)
October 2017 | July 2017 | April 2017 | |
---|---|---|---|
Net Income | 2.02B | 1.02B | 1.16B |
Depreciation | 678M | 636M | 718M |
Changes in Receivables | 32M | -193M | N.A |
Changes in Inventories | -109M | -164M | 34M |
Cash Change | 838M | -276M | 2.20B |
Cash Flow | 0.91B | 737M | 1.77B |
Capital Expenditures | -246M | -278M | -330M |
Investments | 313M | 356M | 53M |
Investing Activity (other) | -2M | N.A | N.A |
Total Investing Cash Flows | 6.04B | 83M | -272M |
Dividends Paid | -622M | -625M | -594M |
Net Borrowings | -4.91B | 579M | 1.30B |
Other Financing Cash Flows | -36M | -5M | -6M |
Cash Flow Financing | -6.14B | -1.14B | 687M |
Exchange Rate Effect | 25M | 45M | 11M |
Medtronic plc dividends (USD)
Ex date | Payment date | Record date | Declared date | Amount | Description | Frequency |
---|---|---|---|---|---|---|
20-12-2022 | 13-01-2023 | 21-12-2022 | N.A | 0.68 | Ordinary Shares | Quarterly |
22-09-2022 | 14-10-2022 | 23-09-2022 | N.A | 0.68 | Ordinary Shares | Quarterly |
23-06-2022 | 15-07-2022 | 24-06-2022 | N.A | 0.68 | Ordinary Shares | Quarterly |
21-12-2020 | 31-12-2020 | 22-12-2020 | N.A | 0.12 | Invesco Dynamic Food & Beverage ETF | Quarterly |
24-09-2020 | 16-10-2020 | 25-09-2020 | N.A | 0.58 | Ordinary Shares | Quarterly |
25-06-2020 | 17-07-2020 | 26-06-2020 | N.A | 0.58 | Ordinary Shares | Quarterly |
26-03-2020 | 17-04-2020 | 27-03-2020 | N.A | 0.54 | Ordinary Shares | Quarterly |
26-12-2019 | 17-01-2020 | 27-12-2019 | N.A | 0.54 | Ordinary Shares | Quarterly |
26-09-2019 | 18-10-2019 | 27-09-2019 | N.A | 0.54 | Ordinary Shares | Quarterly |
05-07-2019 | 25-07-2019 | 08-07-2019 | N.A | 0.54 | Ordinary Shares | Quarterly |
21-03-2019 | 12-04-2019 | 22-03-2019 | N.A | 0.50 | Ordinary Shares | Quarterly |
27-12-2018 | 18-01-2019 | 28-12-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
27-09-2018 | 19-10-2018 | 28-09-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
05-07-2018 | 25-07-2018 | 06-07-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
22-03-2018 | 13-04-2018 | 23-03-2018 | N.A | 0.46 | Ordinary Shares | Quarterly |
28-12-2017 | 19-01-2018 | 29-12-2017 | N.A | 0.46 | Ordinary Shares | N.A |
28-09-2017 | 20-10-2017 | 29-09-2017 | N.A | 0.46 | Ordinary Shares | Quarterly |
05-07-2017 | 26-07-2017 | 07-07-2017 | N.A | 0.46 | Ordinary Shares | Quarterly |
22-03-2017 | 13-04-2017 | 24-03-2017 | N.A | 0.43 | Ordinary Shares | Quarterly |
21-12-2016 | 13-01-2017 | 23-12-2016 | N.A | 0.43 | Ordinary Shares | Quarterly |
27-09-2016 | 21-10-2016 | 29-09-2016 | N.A | 0.43 | Ordinary Shares | Quarterly |
06-07-2016 | 27-07-2016 | 08-07-2016 | N.A | 0.43 | Ordinary Shares | Quarterly |
22-03-2016 | 15-04-2016 | 24-03-2016 | N.A | 0.38 | Ordinary Shares | Quarterly |
22-12-2015 | 15-01-2016 | 24-12-2015 | N.A | 0.38 | Ordinary Shares | Quarterly |
23-09-2015 | 16-10-2015 | 25-09-2015 | N.A | 0.38 | Ordinary Shares | Quarterly |
25-06-2015 | 17-07-2015 | 29-06-2015 | N.A | 0.38 | Ordinary Shares | Quarterly |
Total Valuation
Medtronic Plc has a market cap or net worth of $107.26 billion. The enterprise value is $122.33 billion.
Important Dates
Share Statistics
Medtronic Plc has 1.33 billion shares outstanding.
Valuation Ratios
The trailing PE ratio is 25.9146 and the forward PE ratio is 15.0074. Medtronic Plc's PEG ratio is -1.6141.
Stock Price Statistics
The stock price has increased by 0.0275%. The beta is 0.6735, so Medtronic Plc's price volatility has been lower than the market average.
Income Statement
In the last 12 months, Medtronic Plc had revenue of $30.77 billion and earned $20.44 billion in profits. Earnings per share was $3.04.